作者: Gaetano Rocco , Alessandro Morabito , Paolo Muto
DOI: 10.1016/J.THORSURG.2011.08.010
关键词:
摘要: In spite of numerous clinical trials, the jury is still out on value induction therapy for locally advanced lung cancer. We elected to address this topic from multifaceted views clinicians often involved in cancer management and according most recent NSCLC. The concept a prognostic stratification N2 disease subsets, especially single vs multiple zone, has been introduced may lead new interpretation Ten crucial issues were identified that have an impact approach patients with everyday practice.